The size of the minimally invasive surgical instruments market in Latin America is predicted to grow USD 2.19 billion by 2027 from USD 1.34 billion in 2022, growing at a CAGR of 10.40% from 2022 to 2027.
The rapidly growing aging population in Latin America increased vulnerability to such ailments, and the rising prevalence of chronic diseases can be blamed for the increasing number of surgeries. Furthermore, the increased popularity of minimally invasive procedures over traditional surgeries, the growing frequency of lifestyle-related and chronic illnesses, and technical developments contribute to the growth rate of the Latin American region's minimally invasive surgical instruments market.
Surgical procedures are a superior choice in most chronic illnesses since the senior population is more prone to orthopedic, cardiovascular, and ocular disorders. As a result, with the growing elderly population, demand for various surgical and interventional procedures is predicted to rise. Furthermore, manufacturers should benefit from increased investments by numerous organizations and hospitals to strengthen healthcare infrastructure. As a result, surgical wards in newly built hospitals are expected to be outfitted with innovative surgical equipment to provide a high standard of medical care, which is predicted to boost market expansion over the forecast period.
The minimally invasive surgical devices in Latin America are booming, especially in Mexico and Brazil.
As a result, market participants are investing more in clinical trials, the approval process is taking longer, and more funding is needed for in-depth post-marketing surveillance investigations. It also raises the potential of product recalls, particularly when companies lack the financial resources to conduct additional research to meet FDA data requirements. These delays also hamper the authorization market for less invasive surgical devices. Small manufacturers are likewise restricted from entering the market due to such regulatory adjustments.
This research report on the Latin American minimally invasive surgical instruments market has been segmented and sub-segmented into the following categories:
By Product:
By Application:
By End Users:
By Country:
Geographically, the Latin American region accounted for a moderate share in the global market in 2020. However, this regional market is predicted to hike at a healthy growth rate during the forecast period due to the rising prevalence of chronic diseases, the presence of key players, the development of the healthcare sector, and advancements in diagnostic instrument technology in the region.
Mexico was the dominating region in Latin America in 2020 and is likely to maintain this trend over the projection period, with minor changes. The increasing incidence of neurological, cardiovascular, and other illnesses are among the reasons contributing to the region's rapid growth. The region's rising acceptance of minimally invasive operations.
KEY MARKET PLAYERS:
Companies playing a leading role in the Latin America minimally invasive surgical instruments market profiled in this report are Medtronic plc (Ireland), Ethicon, Inc. (U.S.), Aesculap, Inc. (Germany), Stryker Corporation (U.S.), Smith & Nephew (U.K.), ConMed Corporation (U.S.), Abbott Laboratories (U.S.), Applied Biomedical Resources Corporation (U.S.), Microline Surgical (Japan) and Zimmer Biomet (U.S.).
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Handheld Instruments
5.1.2.1 Introduction
5.1.2.2 Stents
5.1.2.3 Visualizing Scopes
5.1.2.4 Graspers
5.1.2.5 Retractors/Elevators
5.1.2.6 Sutures
5.1.2.7 Dilators
5.1.2.8 Forceps and Spatulas
5.1.2.9 Other Handheld Instruments
5.1.3 Electrosurgical Devices
5.1.3.1 Introduction
5.1.3.2 Electrosurgical Generators
5.1.3.3 Electrosurgical Instruments
5.1.3.4 Electrocautery Devices
5.1.4 Inflation Systems
5.1.4.1 Introduction
5.1.4.2 Balloons
5.1.4.3 Balloon Inflation Devices
5.1.4.4 Other Inflation Systems
5.1.5 Guiding Devices
5.1.5.1 Introduction
5.1.5.2 Guiding Catheters
5.1.5.3 Guidewires
5.1.6 Cutter Instruments
5.1.6.1 Introduction
5.1.6.2 Trocars
5.1.6.3 Rasps
5.1.6.4 Other Cutter Instruments
5.1.7 Auxiliary Instruments
5.1.7.1 Introduction
5.1.7.2 Cannulas
5.1.7.3 Staplers
5.1.7.4 Clamps
5.1.7.5 Closures
5.2 Application
5.2.1 Introduction
5.2.2 Orthopedic Surgery
5.2.3 Gastrointestinal Surgery
5.2.4 Cardiothoracic Surgery
5.2.5 Urological Surgery
5.2.6 Cosmetic/Bariatric Surgery
5.2.7 Gynecological Surgery
5.2.8 Vascular Surgery
5.2.9 Other Applications
5.3 End Users
5.3.1 Introduction
5.3.2 Private Hospitals and Surgical Clinics
5.3.3 Government Hospitals
5.3.4 Academic and Research Institutes
6. Geographical Analysis
6.1 Introduction
6.2 Brazil
6.3 Rest of Latin America
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Medtronic plc (Ireland)
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Ethicon, Inc. (U.S.)
8.3 Aesculap, Inc. (Germany)
8.4 Stryker Corporation (U.S.)
8.5 Smith & Nephew (U.K.)
8.6 ConMed Corporation (U.S.)
8.7 Abbott Laboratories (U.S.)
8.8 Applied Biomedical Resources Corporation (U.S.)
8.9 Microline Surgical (Japan)
8.10 Zimmer Biomet (U.S.)
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.